The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Neurological Effects of Cannabis Use

To the Editor: In his article titled "Persistent and Long-Term Neuropsychiatric Implications of Cannabis Use in Adolescents," published in the June 2017 issue, David S. Mathai, B.S. (1), highlights some important correlations between cannabis use among adolescents and future cognitive impairments, psychosis, and addiction. A significant correlation with brain abnormalities and disproportionate rates of abuse, as noted by Mr. Mathai, warrants further discussion regarding the appropriate minimum age for legal cannabis consumption, and a more stringent set of requirements to obtain the substance in states where adolescents can legally purchase and consume cannabis may be needed.

However, there was scientific evidence missing from the discussion of the article, evidence that may contribute to the understanding of cannabis. For example, a small double-blind, placebo-controlled study showed that low doses of cannabis may be as effective as higher doses for the treatment of pain (2). In regard to illicit drug use, a cross-sectional retrospective survey of persons who use medical cannabis concluded that medical cannabis use was associated with a 64% decrease in opiate use and a 45% increase in life satisfaction among 244 patients with chronic pain (3). This suggests that medical cannabis may help curb the opioid epidemic among adolescents in the United States.

The debate surrounding the efficacy of medical cannabis use will prevail in the immediate future, and it is a debate that needs to be driven by scientific evidence, medical understanding, and intellectual reason.

Brandon Theriault is a first-year medical student at Lincoln Memorial University, Harrogate, Tenn., and Clinical Research Coordinator in the Department of Anesthesiology, Vanderbilt University Medical Center, Nashville.

The author thanks Joseph J. Schlesinger, M.D., Assistant Professor of Anesthesiology Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center.

References

1. Mathai DS: Persistent and long-term neuropsychiatric implications of cannabis use in adolescents. Am J Psychiatry Res J 2017; 12(6):8–10 LinkGoogle Scholar

2. Wilsey B, Marcotte T, Deutsch R, et al.: Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain 2013; 14:136–148 CrossrefGoogle Scholar

3. Boehnke KF, Litinas E, Clauw DJ: Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain 2016; 17:739–744 CrossrefGoogle Scholar